| Name | Title | Contact Details |
|---|
Insider Media is the UK`s largest independent regional B2B magazine, event and online publisher. Insider magazines provide business information of interest to company owners and directors. Events range from black tie award dinners to smaller gatherings for business leaders. Insider has over 100,000 online subscribers to its digital news service.
MeasuredRisk is redefining how business leaders see risk. Combining economic, social, environmental, geopolitical and operational risks, such as cyber, brand sentiment, severe weather and more, MeasuredRisk connects disparate indicators of risk harvested from a multitude of sources and distills them to give the C-suite clear visibility into business risk; enabling key business decisions to be made.
Qumulo Hybrid Cloud File Storage delivers real-time visibility, scale and control of data across on-prem and cloud. Qumulo customers understand storage at a granular level; programmatically configure and manage usage, capacity and performance; and are continuously delighted with new capabilities, 100% usable capacity and direct access to experts.
Gupta Technologies is a Roseville, CA-based company in the Software and Internet sector.
Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing. The proprietary, automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' market leading sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Through Mantis™, the genome interpretation software as a service offering, and Coral™, a biomarker discovery service, Cypher Genomics can improve health care and reduce costs by facilitating improved diagnostic accuracy and earlier interventions, optimizing therapeutic approaches and reducing adverse drug reactions. The gap between the ability to generate whole genome sequences at scale and the primarily manual process of interpretation to date creates a significant unmet need that is well served by the Cypher Genomics solution.